Welcome to the inaugural issue of the *American Journal of Preventive Cardiology* (*AJPC*), the official organ of the American Society for Preventive Cardiology (ASPC) ([www.aspconline.org](http://www.aspconline.org){#intref0010}) and the only US-based journal solely dedicated to preventive cardiology. Starting a medical journal from scratch is a complex endeavor, and although this launch opens a long and arduous road to prominence and sustainability, it also closes a long and arduous road of discussions, resource allocation, planning, and construction that has involved so many of us at the ASPC.

The *AJPC* is under the umbrella of Elsevier, the publisher of many top medical journals, including *Cell*, *The Lancet*, and *JACC*. Our principal goal is to publish quality submissions of original studies, practice position statements and guidelines, reviews and commentaries, real-world experiences, and advances in the business of medicine and in teaching and training techniques. We will strive to become the authoritative journal and beacon of new practical information in a field populated by a broad spectrum of clinical interests, from cardiology to primary care and endocrinology, from nutritional and naturopathic sciences to rehabilitation, exercise physiology, and behavioral medicine. We aim at achieving PubMed indexing within one year and a measurable impact factor within two years.

Why do we need another medical journal? It is because the medical art of preventive cardiology needs a dedicated forum to define, refine, extend, and integrate the competencies of this discipline to improve the care of the many patients seeking to understand and optimally manage their cardiovascular risk. Our journal will be an outlet for pragmatic and highly translational clinical and population-based investigations. Improving patient care should be an underlying goal of every published article. Our discipline has grown so fast that the time is ripe for an agent of change to foster and accelerate the recognition of this medical art, and to help homogenize best practices to standardize care delivery and teaching of the next generation of providers.

We do realize that the world is larger than the US and are fully aware of the good example set by the *European Journal of Preventive Cardiology* (*EJPC*), organ of the European Association of Preventive Cardiology (EAPC). While the *AJPC* originates from the US, we count on our international editorial board to help it achieve worldwide appeal and relevance, given that the need to increase awareness for preventive cardiology is a global effort. We will, in time, reach out to other national and international organizations committed to our discipline, and extend offers to collaborate and synergize on either long-term partnerships or specific topics.

The *AJPC* will consolidate all translational and pragmatic work in our discipline. Our scope involves a broadly defined medical art of prediction, prevention, early detection, risk management, and treatment of cardiovascular conditions ranging from atherosclerosis-based ischemic diseases (e.g., sudden cardiac death, MI, stroke, peripheral arterial disease, etc.) and its co-morbidities (e.g., dyslipidemia, hypertension, obesity, diabetes) and genetic and social contributors, to heart failure, atrial fibrillation, and inherited cardiomyopathies. We also hope to feature occasional thematic issues or series of interest to our readership, with topics such as women's cardiovascular health, cardiovascular risk assessment strategies, mono and polygenic screening, pharmacogenomics studies, and implementation sciences. We will publish translatable and pragmatic investigations, reviews, and commentaries. However, our focus will be the definition, refinement, standardization, and improvement of the medical art we call preventive cardiology, and thus the journal will be structured, in time, with sections aimed at accomplishing all these goals, including:-**This Is How I Practice It.** A window on practice set-ups, care delivery methods, and business integration strategies from academic, hospital, or practice-based operations. This will include a much needed delving into the intricate labyrinth of similarities and differences of clinical lipidology vs. cardio-metabolic medicine vs. preventive cardiology, and what these different models mean for patients, insurers, and referring and co-managing physicians. In addition, this section will also regularly feature an international point of view on what it means to practice preventive cardiology in different countries. The objective will be to create a sense of community for preventive cardiologists around the globe, and to inspire an effort to learn from each other and find common ground on best practices and advances in care delivery. For example, the current changes forced by the worldwide COVID-19 epidemic are a strong impetus to developing telemedicine as a regular feature of preventive cardiology, which will have plenty of patients preferring to use it over physical encounters even when we return to normal operations.-**This Is How I Teach It.** Reports on best methods to teach healthcare providers and trainees about the many facets of knowledge necessary to achieve full competency in preventive cardiology. This will include explanations of proven or novel structures and methods of teaching, as well as retrievable presentations on a wide range of topics, from the epidemiology of cardiovascular diseases to the tools for cardiovascular risk assessment, from the pathogenesis of dyslipidemia to the drivers and stages of atherogenesis, from the use of cardio-protective drugs to genetic risk assessment, from the use and interpretation of non-invasive imaging approaches to the challenges of implementation of lifestyle interventions. The objective will be to create a database of ever-growing and ever-improving didactic resources for all readers and subscribers to use in their own institutions.-**This, Too, Is Preventive Cardiology.** Reports on how to incorporate into our clinical domain some care practices or conditions that historically have been seen as related but separate jurisdictions. These include cardiac rehabilitation, naturopathic medicine, medical genetics, addiction medicine, clinical pharmacology, nutritional services, and clinical psychology. The objective will be to provide the tools for a comprehensive implementation of all essential elements of preventive cardiology care.-**Beyond the Standard of Care.** Analyses and investigations of patient-based registries and bio-repositories aimed at improving knowledge of disease pathogenesis, genetic determinants, real-world effectiveness of therapeutic modalities, obstacles to prescription adherence including cost considerations, insurance approval processes of novel medications, and patient experiences. The objective will be to incentivize the creation and use of patient registries in preventive cardiology practices as a tool to expand offerings of common real-world studies such electronic medical record investigations.

In this inaugural issue we have featured just a sampling of much more to come. Each issue will have an opening message from the president of the ASPC to highlight the current activities of our organization; this month's message provides a historical perspective of the ASPC and defines its commitment and expectations for the new journal. Of particular current interest is a special article on COVID-19 and what the epidemic and the societal reaction to it means for the field of preventive cardiology. In addition, we feature a practical and enjoyable opinion piece on the ten things a provider needs to know about 10 CVD risk factors, a review on cardiovascular risk assessment as the foundation for preventive cardiology, one on the treatment of hypertension in the elderly, and commentaries on obesity as a preventive cardiology problem, integrating diabetes management into preventive cardiology, and the need for doctors to understand healthcare economics. Also, in this first issue are original studies, which will form an increasingly prominent part of each issue.

The AJPC is delighted to have recruited an esteemed group of associate editors and editorial board members of proven record, international renown, and expertise in preventive cardiology and related disciplines. The success of the journal will depend in large part on the quality of submissions, the fairness and speed of the review process, and the technical friendliness of the interface for both authors and reviewers. We will promise maximum attention to optimizing the latter two elements, and will rely on all of you readers to submit to our journal your best ideas and study results, thus helping us achieve a steady and sustainable state in the very competitive peer-review publishing field. It is a community effort and we trust that the preventive cardiology community will work in its self-interest to support this endeavor. We encourage all of our ASPC members, non-member readers, and any expert in the field to provide input and suggestions to help us make this the premier journal and guiding light in this expanding field.
